{"id":53,"date":"2021-02-05T14:52:13","date_gmt":"2021-02-05T13:52:13","guid":{"rendered":"https:\/\/campus-psychiatrie.de\/site\/?page_id=53"},"modified":"2022-03-09T10:36:25","modified_gmt":"2022-03-09T09:36:25","slug":"veroeffentlichungen","status":"publish","type":"page","link":"https:\/\/campus-psychiatrie.de\/?page_id=53","title":{"rendered":"Ver\u00f6ffentlichungen"},"content":{"rendered":"\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n
\r\n

Publikationen gesamt:
<\/strong>Pubmed Februar 2022 (11.02.2022)
<\/strong><\/span><\/p>\r\n<\/td>\r\n

123<\/strong><\/span><\/td>\r\n<\/tr>\r\n
Citations<\/span><\/td>\r\n4.943<\/span><\/td>\r\n<\/tr>\r\n
h-index<\/span><\/td>\r\n39<\/span>
<\/span><\/strong><\/span><\/td>\r\n<\/tr>\r\n
i10-index<\/span><\/td>\r\n80
<\/span><\/td>\r\n<\/tr>\r\n
(Google Scholar 11.02.2022)
Link zu scholar google<\/a>
<\/span><\/td>\r\n		\u00a0<\/span><\/td>\r\n<\/tr>\r\n
ResearchGate (RG) Score:
\u00a0(11.02.2022)
<\/span><\/td>\r\n		40,61
<\/span><\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n

https:\/\/www.researchgate.net\/profile\/Waldemar-Greil<\/span><\/a><\/p>\r\n

Pr<\/strong>of. Dr. med. Waldemar Greil<\/strong><\/span>
Wissenschaftlicher Beirat, ehemaliger \u00c4rztlicher Direktor 1992 – Februar 2007,<\/span>
Sanatorium Kilchberg Psychiatrische Privatklinik<\/span>
Ausserplanm\u00e4ssiger Professor, Universit\u00e4t M\u00fcnchen (LMU)
<\/span>Gastwissenschaftler (Schwerpunkt Arzneimittelsicherheit, Bipolare St\u00f6rung),\u00a0Psychiatrische Klinik, Universit\u00e4t M\u00fcnchen (LMU)<\/span><\/p>\r\n


<\/span>Literaturverzeichnis ab 2010 (Stand 11.02.2022)<\/span><\/strong>

Publikationen Prof. W. Greil, erschienen seit 2010
<\/strong><\/span><\/p>\r\n

de Bardeci M, Greil W, Stassen H, Willms J, K\u00f6berle U, Bridler R, Hasler G, Kasper S, R\u00fcther E, Bleich S, Toto S, Grohmann R, Seifert J.\u00a0Dear Doctor Letters regarding citalopram and escitalopram: guidelines vs real-world data.<\/a><\/span> Eur Arch Psychiatry Clin Neurosci. 2022 Feb 25. doi: 10.1007\/s00406-022-01392-x. Online ahead of print.PMID:\u00a035217913<\/span><\/p>\r\n

Greil W, De Bardeci M, Seifert J, Bernegger X, Cattapan K, Stassen H, Wagner AL, Sieberer M, Grohmann R, Toto S. Treatment of Depression: Are psychotropic drugs appropriately dosed in women and in the elderly? Dosages of psychotropic drugs by sex ande age in routine clinical practice.<\/b>Hum Psychopharmacol 2022 Jan; 37(1):e2809.doi:10.1002\/hup.2809

Seifert J, F\u00fchrmann F, Reinhard MA, Engel RR, Bernegger X, Bleich S, St\u00fcbner S, R\u00fcther E, Toto S, Grohmann R, Sieberer M, Greil W. Sex differences in pharmacological treatment of major depressive disorder: results from the AMSP pharmacovigilance program from 2001 to 2017. J Neural Transm (Vienna). 2021 May 11. 128(6):827-843.doi: 10.1007\/s00702-021-02349-5.

<\/b><\/span>Seifert J, Engel RR, Bernegger X, F\u00fchrmann F, Bleich S, St\u00fcbner S, Sieberer M, Greil W, Toto S, Grohmann R.\u00a0Time trends in pharmacological treatment of major depressive disorder: Results from the AMSP Pharmacovigilance Program from 2001-2017.\u00a0<\/span><\/strong>J Affect Disord. 2021 Feb 15;281:547-556. doi: 10.1016\/j.jad.2020.12.073. Epub 2020 Dec 25.\u00a0PMID: 33401143<\/span><\/p>\r\n


<\/strong><\/span>Greil W.: Unappropriate recommendation grades for carbamazepine and valproate. <\/strong>Nervenarzt. 2019 Jul 19. doi: 10.1007\/s00115-019-0763-x. [Epub ahead of print] German. \u00a0

Toto S, Grohmann R, Bleich S, Frieling H, Maier HB, Greil W, Cordes J, Schmidt-Kraepelin C, Kasper S, St\u00fcbner S, Degner D, Druschky K, Zindler T, Neyazi A.: Psychopharmacological Treatment of Schizophrenia Over Time in 30 908 Inpatients: Data From the AMSP Study. <\/strong>Int J Neuropsychopharmacol. 2019 Sep 1;22(9):560-573. doi: 10.1093\/ijnp\/pyz037. Free PMC Article \u00a0

Greil W, Zhang X, Stassen H, Grohmann R, Bridler R, Hasler G, Toto S, Bleich S, Kasper S.:Cutaneous adverse drug reactions to psychotropic drugs and their risk factors – a case-control study. <\/strong>Eur Neuropsychopharmacol. 2019 Jan;29(1):111-121. doi: 10.1016\/j.euroneuro.2018.10.010. Epub 2018 Nov 10. Free Article \u00a0

Gregor Hasler, Martin Preisig, Thomas J. M\u00fcller, Wolfram Kawohl, Jean-Michel Aubry, Waldemar Greil: Behandlungsempfehlungen der Schweizerischen Gesellschaft f\u00fcr Bipolare St\u00f6rungen (SGBS) Bipolare St\u00f6rungen: Update 2019 <\/strong>Swiss Med Forum. 2019;19(3334):537-546, DOI: https:\/\/doi.org\/10.4414\/smf.2019.08325 \u00a0

St\u00fcbner S, Grohmann R, Greil W, Zhang X, M\u00fcller-Oerlinghausen B, Bleich S, R\u00fcther E, M\u00f6ller HJ, Engel R, Falkai P, Toto S, Kasper S, Neyazi A.:Suicidal Ideation and Suicidal Behavior as Rare Adverse Events of Antidepressant Medication: Current Report from the AMSP Multicenter Drug Safety Surveillance Project.<\/strong>Int J Neuropsychopharmacol. 2018 Sep 1;21(9):814-821. doi: 10.1093\/ijnp\/pyy048. Free PMC Article
\u00a0 \u00a0
Druschky K, Bleich S, Grohmann R, Engel RR, Kleimann A, St\u00fcbner S, Greil W, Toto S.: Use and safety of antiepileptic drugs in psychiatric inpatients-data from the AMSP study.<\/strong>Eur Arch Psychiatry Clin Neurosci. 2018 Mar;268(2):191-208. doi: 10.1007\/s00406-017-0827-5. Epub 2017 Aug 1.

Niedrig D.F., G\u00f6tt C., Fischer A., M\u00fcller S.T., Greil W., Bucklar G., Russmann S.: Second-generation antipsychotics in a tertiary care hospital: prescribing patterns, metabolic profiles and drug interactions. <\/strong>Int Clin Psychopharmacol. 2016 Jan;31(1):42-50.doi.1097\/YIC.0000000000000103. \u00a0

Kleimann, A., Schrader, V., St\u00fcbner, S., Greil, W., Kahl, K.G., Bleich, S., Grohmann, R.,\u00a0 Frieling, H., Toto, S.: Psychopharmacological treatment of 1650 in-patients with acute mania \u2013 data from the AMSP study.<\/strong> J Affect Disord. 2016 Feb; 191:164-71.doi: 10.1016\/j.jad.2015.11.037. \u00a0

Poppe, Ch., M\u00fcller, S.T., Greil, W., Walder, A., Grohmann, R., St\u00fcbner, S.: Pharmacotherapy for obsessive compulsive disorder in clinical practice \u2013 Data of 842 inpatients from the International AMSP Project between 1994 and 2012.<\/strong> J Affect Disord. 2016 Aug;200:89-96. doi: 10.1016\/j.jad.2016.04.035

Friedrich, M.E., Akimova, E., Huf, W., Konstantinidis, A., Papageorgiou, K., Winkler, D., Toto, S., Greil,W., Grohmann, R., Kasper,S.: Drug-induced liver injury during antidepressant treatment: Results of AMSP, a drug surveillance program.<\/strong> Int J Neuropsychopharmacol. 2016 Apr 20;19(4). pii: pyv126. doi: 10.1093\/ijnp\/pyv126. Print 2016 Apr.<\/span>

Bridler R., H\u00e4berle A., M\u00fcller S. T., Cattapan K., Grohmann R., Toto S., Kasper S., Greil W.: Psychopharmacological treatment of\u00a0 2<\/strong>,195 in-patients with borderline personality disorder: A comparison with other psychiatric disorders. <\/strong>European Neuropsychopharmacology (2015) 25, 763-772. \u00a0

M\u00fcller, S.T., Greil, W., Poppe, Ch.:Optionen der medikament\u00f6sen Therapie (Les options de traitement m\u00e9dicamenteux)<\/strong>. InFo: Neurologie & Psychiatrie (2015), Vol. 13(6).\u00a0 \u00a0

Kleimann, A., Schrader, V., St\u00fcbner, S., Greil, W., Bleich, St., Grohmann, R.,\u00a0 Frieling, H., Toto, S.: Psychopharmacological treatment of acute mania in 1650 in-patients \u2013 an update.<\/strong> (soll im Journal of Affective Disorders eingereicht werden)<\/span>

Poppe, Ch., M\u00fcller, S.T., Greil, W., Walder, A., Grohmann, R., St\u00fcbner,S.: Pharmacotherapy for obsessive compulsive disorder in clinical practice- Data of 842 inpatients from the International AMSP Project between 1994-2012.<\/strong> J.Affect.Disord.2016 Aug;200:89-96.doi:10.1016\/j.jad.2016.04.035<\/span>

Friedrich, M.E., Akimova, E., Huf, W., Konstantinidis, A., Papageorgiou, K., Winkler, D., Toto, S., Greil,W., Grohmann, R., Kasper,S.: Drug-induced liver injury during antidepressant treatment: Results of AMSP, a drug surveillance program.<\/strong> Int J Neuropsychopharmacol. 2016 Apr 20;19(4). pii: pyv126. doi: 10.1093\/ijnp\/pyv126. Print 2016 Apr. \u00a0<\/strong>

Spindelegger C., Papageorgiu K., Grohmann R., Engel,R.R., Greil W., Konstantinidis A., Agelink M.W., Bleich S., R\u00fcther E.,Toto S., Kasper S.: Cardiovascular adverse reaction during antidepressant treatment: A drug surveillance report of German-speaking countries between 1993 and 2010. <\/strong>-Int J Neuropsychopharmacol.<\/a>\u00a02014 Oct 31;18(4). pii: pyu080. doi: 10.1093\/ijnp\/pyu080.

Second-generation antipsychotics in a tertiary care hospital: prescribing patterns, metabolic profiles, and drug interactions.
<\/a><\/strong>Niedrig DF, G\u00f6tt C, Fischer A, M\u00fcller ST,\u00a0Greil W, Bucklar G, Russmann S. Int Clin Psychopharmacol. 2016 Jan;31(1):42-50. doi: 10.1097\/YIC.0000000000000103

Waldemar Greil, Anne H\u00e4berle, Thomas Schuhmann, Renate Grohmann, Pierre Baumann: Age and adverse drug reactions from psychopharmacological treatment Data from the AMSP drug surveillance programme in Switzerland,<\/strong> Swiss Med Wkly. 2013;143:w13772
<\/strong>
<\/strong>Greil, W. & Poppe, C. (2013). Psychologen in der Psychiatrie: Beispiel Psychiatrische Privatklinik Sanatorium Kilchberg bei Z\u00fcrich. In H. Znoj & T. Berger (Hrsg.), Die Kunst und Wissenschaft der Psychotherapie (S. 251-254).<\/strong> Bern: Huber.
\u00a0
<\/strong>Gabriel Felleiter K., Greil W.,\u00a0 Hasler G.: Consensus Statement: Stellenwert von Asenapin (Sycrest\u00ae) in der Behandlung von Bipolaren St\u00f6rungen. Clinical Experience Program (CEP): Erste praktische Erfahrungen in der Schweiz. <\/strong>Internationale Zeitschrift f\u00fcr \u00e4rztliche Fortbildung Nr. 17\/August 2013
<\/a><\/strong>
<\/strong>Anne Haeberle, Waldemar Greil*, Stefan Russmann and Renate Grohmann *corresponding author: Mono- and combination drug therapies in hospitalized patients with bipolar depression. Data from the European drug surveillance program AMSP BMC Psychiatry 2012<\/strong>, 12:153 (article: „higly accessed) http:\/\/www.biomedcentral.com\/1471-244X\/12\/153<\/a><\/strong> http:\/\/www.biomedcentral.com\/content\/pdf\/1471-244X-12-153.pdf<\/a><\/strong>

<\/strong>Greil W., H\u00e4berle A., Schuhmann T., Grohmann R., Baumann P.: Age and adverse effects of psychopharmacological treatment. Data from the drug surveillance program AMSP in Switzerland.<\/strong> Swiss Med Wkly 2013 Jul 2; 143:w13772<\/span>

Zorina O., Haueis P, Greil W, Grohmann R, Kullak-Ublick G, Russmann S.: Comparative Performance of Two Drug Interaction Screening Programs Analyzing a Cross-sectional Prescription Dataset of 84<\/strong>,625 Psychiatric Inpatients. Drug\u00a0Saf. 2013 Apr;36(4):247-58.\u00a0
<\/span>
Zorina OL, Haueis P, Greil W, Grohmann R, Kullak-Ublick GA, Russmann S:Comparative Performance of Two Drug Interaction Screening Programs Analyzing a Cross-sectional <\/strong>Prescription Dataset of 84,625 Psychiatric Inpatients, Pharmacopsychiatry 2012; 45 – A28, doi: 10.1055\/s-0032-1326771.\u00a0<\/span>

Waldemar Greil, Anne H\u00e4berle, Patrick Haueis, Renate Grohmann, Stefan Russmann: <\/span>Pharmacotherapeutic Trends in 2231 Psychiatric Inpatients with Bipolar Depression from the International AMSP Project between 1994 and 2009.\u00a0 <\/strong><\/span>J Affect Disord. 2012 Feb;136(3):534-42. Epub 2011 Nov 30.
<\/a><\/span>
Haueis, G., Greil, W., Huber, M., Grohmann, R., Kullack-Ublick, G.A., Russmann,S.: Evaluation of\u00a0 drug interactions in a large sample of psychiatric inpatients: a data interface for mass analysis with clinical decision support software.<\/strong><\/span>
Clin Pharmacol Ther. 2011 Oct;90(4):588-96. Epub 2011 Aug 24.<\/a><\/span>

St\u00fcbner,S., Grohmann,R., Greil,W.: Letters to the Editor (Reply): Suicidal Risk During Antidepressant Treatment. <\/strong>J Clin Psychiatry 2011:72(5):722.<\/span>

Greil W, von Stralendorff I, Mandl\u00a0 H.: \u201eBlended learning\u201c in der \u00e4rztlichen Fortbildung. Evaluation eines innovativen Fortbildungszyklus \u201eBipolare St\u00f6rungen und verwandte Erkrankungen\u201c.<\/strong><\/span>
Der Nervenarzt 2011:82(7):895-901.<\/span>

Hasler,G., Preisig,M., M\u00fcller,T., Holsboer-Trachsler,E., Conus,Ph., Aubry,J.-M.. Greil, W.: <\/span>Behandlungsempfehlungen f\u00fcr Bipolare St\u00f6rungen der Schweizerischen Gesellschaft f\u00fcr Bipolare St\u00f6rungen. <\/strong>Schweiz Med Forum 2011; 11(18):308-313..<\/span>

Walder,A., Greil, W.: Unerw\u00fcnschte Wirkungen unter Psychopharmaka im Alter. Spezielle Risiken, Schutzmechanismen, Prognose. <\/strong>Praxis (Bern 1994) 2011, Dez. 14, 100(25):1529-32.<\/span>

Severus WE, Lipkovich IA, Licht RW, Young AH, Greil W, Ketter T, Deberdt W, Tohen M.: In search of optimal lithium levels and olanzapine doses in the long-term treatment of\u00a0 bipolar I disorder. A post-hoc analysis of the maintenance study by Tohen et al. 2005.<\/strong> Eur Psychiatry 2010 Dec:25(8):443-9<\/span>

St\u00fcbner S, Grohmann W, von Stralendorff I, R\u00fcther E, M\u00f6ller HJ, M\u00fcller-Oerlinghausen B, Engel R, Horvath A, Greil W.: Suicidality as Rare Adverse Event of Antidepressant Medication. Report from the AMSP Multicenter Drug Safety Surveillance Project.<\/strong> J Clin Psychiatry. 2010 Oct;71(10):1293-307. Epub 2010 Aug 10.<\/a><\/span>

Gillhoff K, Gaab J, Emini L, Maroni C, Tholuck J, Greil W.:\u00a0J Clin Psychiatry. 2010;12(5).Effects of a Multimodal Lifestyle Intervention on Body Mass Index in Patients With Bipolar Disorder \u2013 A Randomized Controlled Trial.<\/strong>Prim Care Companion J Clin Psychiatry.<\/a> 2010;12(5)<\/a>.<\/span>

Publikationen nachfolgend: Auswahl, 1998\u20132009<\/strong><\/span>

Artikel in Fachzeitschriften<\/span><\/strong>
Greil W, von Stralendorff I. \u201e\u2026M\u00e4nner sind so verletzlich..\u201c- Wird unsere Medizin dem Mann gerecht? [„…Men are so vulnerable …“ does our medicine do justice to men?]. MMW-Fortschr. Med. 2009 Sep 3;151(36):30. German. \u00a0

Walder A, Greil W, Baumann P. Letter to the Editor: Drug-induced Pisa syndrome under quetiapine. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2009 Oct 1;33(7):1286-7. Epub 2009 Jul 29. \u00a0

Severus WE, Kleindienst N, Evoniuk G, Bowden C, M\u00f6ller HJ, Bohus M, Frangou S, Greil W, Calabrese JR. Is the polarity of relapse\/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study. J Affect Disord. 2009 Jun;115(3):466-70. Epub 2008 Nov 20.<\/span>

Giersch D, von Stralendorff I, Greil W. Die Behandlung von bipolaren St\u00f6rungen nach den Leitlinien des Canadian Network for Mood and Axiety Treatments. Nervenheilkunde 27 (2008): 133-144.<\/span>

Severus WE, Kleindienst N, Seem\u00fcller F, Frangou S, M\u00f6ller HJ, Greil W<\/span>
What is the optimal serum lithium level in the long-term treatment of bipolar disorder – a review? Bipolar Disord 10 (2008): 231-237. Review.<\/span>

Tohen M, Bowden CL, Smulevich AB, Bergstrom R, Quinlan T, Osuntokun O, Wang WV, Oliff HS, Martenyi F, Kryzhanovskaya LA, Greil W. Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes. Br J Psychiatry 192 (2008): 135-143.<\/span>

Walder A, Greil W, Baumann P, Purpura and ecchymosis under carbamazepine, chloral hydrate and melitracen-flupentixol. Eur J Dermatol 18 (2008): 103-104.<\/span>

Giersch D, Greil W,CME: Pharmakotherapie bipolarer St\u00f6rungen. Erweiterte Optionen f\u00fcr das individuelle Krankheitsbild. Der Neurologe und Psychiater 7 (2007): 24-30<\/span>

Grunze H, Adli M, Bauer M, Berger M, Bergmann A, Br\u00e4unig P, Bschor T, Falkai P, Gastpar M, Greil W, Kasper S, Kr\u00fcger S, Laux G, M\u00fcller WE, Naber D, Walden J, Klinischer Stellenwert der Valproat-Therapie bei bipolaren St\u00f6rungen.Fortschr Neurol Psychiatr 75 (2007): 220-235. Review.<\/span>

Kleindienst N, Severus WE, Greil W., Are serum lithium levels related to the polarity of recurrence in bipolar disorders? Evidence from a multicenter trial. Int Clin Psychopharmacol 22 (2007): 125-131.<\/span>

Wolfsperger M, Greil W, R\u00f6ssler W, Grohmann R, Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004. J Affect Disord 99 (2007): 9-17.<\/span>

Greil W, Schmidt D, Affektstabilisatoren bei verschiedenen Formen bipolarer St\u00f6rungen.<\/span>Die Psychiatrie 2 (2006): 102-111.<\/span>

Severus WE, Kleindienst N, Greil W, Re-evaluation of randomized controlled trials of lithium monotherapy (letter). Bipolar Disord 8 (2006): 519-520.<\/span>

Wolfsperger M, Greil W <\/span>Galactorrhea during treatment with trimipramine. A case report.<\/span>Pharmacopsychiatry 38 (2005): 326-327.<\/span>
\u00a0<\/span>
Zullino D, Mayland G, Schmidt LG, Fahndrich E, Greil W, Horvath A, Ruther E, Engel R, Hippius H, Baumann <\/span>Prescribing practices in German and Swiss psychiatric university and in non-university hospitals: national differences. Int J Clin Pharmacol Ther 43 (2005): 339-349.<\/span>

Tohen M, Greil W, Calabrese JR et al <\/span>Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial. Am J Psychiatry 162 (2005): 1281-1290.<\/span>

Kleindienst N, Severus WE, M\u00f6ller HJ, Greil W<\/span>
Is polarity of recurrence related to serum lithium level in patients with bipolar disorder? <\/span>Eur Arch Psychiatry Clin Neurosci 255 (2005): 72-74. Review.<\/span>

Kleindienst N, Engel RR, Greil W <\/span>Psychosocial and demographic factors associated with response to prophylactic lithium. A systematic review for bipolar disorders. Psychological Med 35 (2005): 1685-1694.<\/span>

Kleindienst N, Engel RR, Greil W <\/span>Which clinical factors predict response to prophylactic lithium? A systematic review for bipolar disorders.<\/span>
Bipolar Disord 7 (2005): 404-417. Review.<\/span>

Kleindienst N, Greil W <\/span>Are illness concepts a powerful predictor of adherence to prophylactic treatment in bipolar disorder?<\/span>
J Clin Psychiatry 65 (2004): 966-974.<\/span>

Amann B, Schestak S, Grunze H, Greil W<\/span>
Facharztausbildung online. Neurotransm (2004 Nov): 42-44.<\/span>
Artikel „Facharztausbildung online“ in NEUROTRANSMITTER 11\/04<\/span>

Greil W, Kleindienst N<\/span>
Concepts in the treatment of bipolar disorder.<\/span>
Acta Psychiatr Scand Suppl 418 (2003):41-46. Review.<\/span>

Kleindienst N, Greil W<\/span>
Lithium in the long-term treatment of bipolar disorders.<\/span>
Eur Arch Psychiatry Clin Neurosci 252 (2003): 120-125. Review.<\/span>

Erazo N, Greil W<\/span>
Konfrontieren statt vermeiden: Warum Angstpatienten sich ihren Ausl\u00f6sern stellen m\u00fcssen.<\/span>
MMW Fortschr Med 26 (144) (2002): 29-32.<\/span>

Kleindienst N, Greil W<\/span>
Inter-episodic morbidity and drop-out under carbamazepine and lithium in the maintenance treatment of bipolar disorder. Psychol Med 32 (2002): 493-501.<\/span>

Greil W, Horvath A, Sassim N, Erazo N, Grohmann R<\/span>
Disinhibition of libido: an adverse effect of SSRI?<\/span>
J Affect Disord 62 (2001): 225-228.<\/span>
\u00a0<\/span>
Kleindienst N, Greil W<\/span>
Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: results of the MAP-Study. <\/span>Neuropsychobiology 42 Suppl 1 (2000): 2-10.<\/span>

Erazo N, van der Lee T, Greil W<\/span>
Zum plastischen Gestalten in der Kunsttherapie: Ein Bildhauerprojekt an einer Psychiatrischen Klinik. <\/span>Psychiatr Prax 27 (2000): 35-39.<\/span>

Greil W, Kleindienst N<\/span>
Lithium versus carbamazepine in the maintenance treatment of bipolar II disorder and bipolar disorder not otherwise specified. Int Clin Psychopharmacol 14 (1999): 283-285.<\/span>

Greil W, Kleindienst N<\/span>
The comparative prophylactic efficacy of lithium and carbamazepine in patients with bipolar I disorder. <\/span>Int Clin Psychopharmacol 14 (1999): 277-281.<\/span>

Kleindienst N, Greil W, R\u00fcger B, M\u00f6ller HJ<\/span>
The prophylactic efficacy of lithium \u2013 transient or persistent?<\/span>
Eur Arch Psychiatry Clin Neurosci 249 (1999): 144-149. Review.<\/span>
\u00a0<\/span>
Greil W, Kleindienst N, Erazo N, M\u00fcller-Oerlinghausen B<\/span>
Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder. <\/span>J Clin Psychopharmacol 18 (1998): 455-460.<\/span>

Monographien<\/strong>

Greil W, Giersch D: Stimmungsstabilisierende Therapien bei manisch-depressiven (bipolaren) Erkrankungen. Ein Fachbuch f\u00fcr Betroffene, Angeh\u00f6rige und Therapeuten.<\/span>Thieme, 1. Auflage, 2006. \u00a0 <\/span><\/p>\r\n

Greil W, Sassim N, Str\u00f6bel-Sassim C: Die manisch-depressive Krankheit.<\/span>
Thieme, 2. Auflage, 1996 (vergriffen) \u00a0<\/span>

Lehrbuchbeitr\u00e4ge<\/strong><\/span>

Greil W, von Stralendorff I. Bipolare St\u00f6rungen: Medikament\u00f6se Therapie.<\/span>
(In: Voderholzer U, Hohagen F (Hrsg.), Therapie psychischer Erkrankungen. State of the Art. 2011 \/ 2011, 6. Auflage, Elsevier), S. 181-190<\/span>

Greil W, von Stralendorff I.:\u00a0 Bipolare St\u00f6rungen:<\/span>
Medikament\u00f6se Therapie in \u201eTherapie psychischer Erkrankungen. State of the Art\u201c (Voderholzer U, Hohagen F, Hrsg.), 5. Auflage, Elsevier 2010, S. 206-218<\/span>

Greil W, von Stralendorff I: Bipolare St\u00f6rungen: Medikament\u00f6se Therapie in \u201eTherapie psychischer Erkrankungen. State of the Art\u201c (Voderholzer U, Hohagen F, Hrsg.), 4. Auflage, Elsevier 2009, S. 208-221. \u00a0 Greil W, Giersch D: Bipolare St\u00f6rungen: Medikament\u00f6se Therapie in \u201eTherapie psychischer Erkrankungen. State of the Art\u201c (Voderholzer U, Hohagen F, Hrsg.), 3. Auflage, Elsevier 2008, S. 207-221.<\/span>

Greil W, Giersch D: Bipolare St\u00f6rungen: Medikament\u00f6se Therapie in \u201eTherapie psychischer Erkrankungen. State of the Art\u201c (Voderholzer U, Hohagen F, Hrsg.), 2. Auflage, Elsevier 2007, S. 186-199.<\/span>

Greil W, Schmidt D: Bipolare St\u00f6rungen: Medikament\u00f6se Therapie in<\/span>
\u201eTherapie psychischer Erkrankungen. State of the Art\u201c<\/span>
(Voderholzer U, Hohagen F, Hrsg.), 1. Auflage, Elsevier 2006, S. 134-145.<\/span>

Greil W, Giersch D: Bipolare St\u00f6rungen: Medikament\u00f6se Therapie<\/span>
in „Therapie psychischer Erkrankungen. State of the Art.“<\/span>
(Voderholzer U, Hohagen F, Hrsg.), 2. Auflage, Elsevier 2006, S. 181-199.<\/span><\/p>\r\n

Greil W, Giersch D, Kleindienst N: Medikament\u00f6se Rezidivprophylaxe affektiver<\/span>
St\u00f6rungen in „Therapie psychiatrischer Erkrankungen“.<\/span>
(M\u00f6ller H-J, Hrsg.), 3. Auflage, Thieme 2006, S. 458-485.<\/span>
Interview <\/span>Therapie der bipolaren Depression \u2013 Evidenz-basierte Irrungen und Wirrunge. <\/span>Psychiatrie & Neurologie Aktuell, April 2004.<\/span><\/p>\r\n

\r\n\r\n<\/span><\/p>\r\n

<\/figure>\r\n

<\/span><\/p>","protected":false},"excerpt":{"rendered":"

Publikationen gesamt: Pubmed Februar 2022 (11.02.2022) 123 Citations 4.943 h-index 39 i10-index 80 (Google Scholar 11.02.2022)Link zu scholar google \u00a0 ResearchGate (RG) Score:\u00a0(11.02.2022) 40,61 https:\/\/www.researchgate.net\/profile\/Waldemar-Greil Prof. Dr. med. Waldemar GreilWissenschaftlicher Beirat, ehemaliger \u00c4rztlicher Direktor 1992 – Februar 2007,Sanatorium Kilchberg Psychiatrische PrivatklinikAusserplanm\u00e4ssiger Professor, Universit\u00e4t M\u00fcnchen (LMU) Gastwissenschaftler (Schwerpunkt Arzneimittelsicherheit, Bipolare St\u00f6rung),\u00a0Psychiatrische Klinik, Universit\u00e4t M\u00fcnchen (LMU) Literaturverzeichnis … <\/p>\n

\u201eVer\u00f6ffentlichungen\u201c<\/span> weiterlesen<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-53","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/campus-psychiatrie.de\/index.php?rest_route=\/wp\/v2\/pages\/53","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/campus-psychiatrie.de\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/campus-psychiatrie.de\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/campus-psychiatrie.de\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/campus-psychiatrie.de\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=53"}],"version-history":[{"count":30,"href":"https:\/\/campus-psychiatrie.de\/index.php?rest_route=\/wp\/v2\/pages\/53\/revisions"}],"predecessor-version":[{"id":566,"href":"https:\/\/campus-psychiatrie.de\/index.php?rest_route=\/wp\/v2\/pages\/53\/revisions\/566"}],"wp:attachment":[{"href":"https:\/\/campus-psychiatrie.de\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=53"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}